Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-008569
Filing Date
2018-08-07
Accepted
2018-08-07 16:54:33
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1301869
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cbmg_ex311.htm EX-31.1 18745
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cbmg_ex321.htm EX-32.1 10089
4 IMAGE cbmg_10q014.jpg GRAPHIC 29034
  Complete submission text file 0001654954-18-008569.txt   3685148

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cmbg-20180630.xml EX-101.INS 480434
6 XBRL TAXONOMY EXTENSION SCHEMA cmbg-20180630.xsd EX-101.SCH 35543
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmbg-20180630_cal.xml EX-101.CAL 51674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmbg-20180630_def.xml EX-101.DEF 99326
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmbg-20180630_lab.xml EX-101.LAB 241400
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmbg-20180630_pre.xml EX-101.PRE 189891
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 18998821
SIC: 2836 Biological Products, (No Diagnostic Substances)